Abstract
Gene patenting is now a familiar commercial practice, but there is little awareness that several patents claim ownership of the complete genome sequence of a prokaryote or virus. When these patents are analysed and compared to those for other biological entities, it becomes clear that genome patents seek to exploit the genome as an information base and are part of a broader shift towards intangible intellectual property in genomics.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Nuffield Council on Bioethics The Ethics of Patenting DNA (Nuffield Council on Bioethics, London, 2002).
Heller, M. A. & Eisenberg, R. S. Can patents deter innovation? The anticommons in biomedical research. Science 280, 698–701 (1998).
Organisation for Economic Co-operation and Development Genetic Inventions, Intellectual Property Rights, and Licensing Practices: Evidence and Policies (OECD, Paris, 2002).
Gold, E. R. SARS genome patent: symptom or disease? Lancet 361, 2002–2003 (2003).
Gene patents and the public good [Editorial]. Nature 423, 207 (2003).
Demaine, L. J. & Fellmeth, A. X. Natural substances and patentable inventions. Science 300, 1375–1376 (2003).
Barton, J. H. Reforming the patent system. Science 287, 1933–1934 (2000).
US Patent and Trademarks Office Utility examination guidelines. Fed. Regist. 66, 1092–1099 (2001).
Cornish, W. R., Llewellyn M. & Adcock, M. Intellectual Property Rights and Genetics: a Study into the Impact and Management of Intellectual Property Rights Within the Healthcare System (Public Health Genet. Unit, Cambridge, 2003).
Human Genome Sciences 1996 Annual Report (Human Genome Sciences, Rockville, Maryland, 1997).
Shreeve, J. The Genome War (Knopf, New York, 2004).
Barton, J. H. Patents, genomics, research and other diagnostics. Acad. Med. 77, 1339–1347 (2002).
US Supreme Court. Diamond v. Chakrbarty 447, US 303 (US Reports, 1980).
World Trade Organization. The Results of the Uruguay Round of Multilateral Trade Negotiations: the Legal Texts (Cambridge Univ. Press, Cambridge, 1999).
Stetter, K. O. Thermococcus AV4 and enzymes produced by the same. USPTO 5,714,373 (US Patent and Trademark Office, 1998).
Triplett, E. W. Microorganisms. USPTO 5,908,758 (US Patent and Trademark Office, 1999).
Bottone, E., J. & Peluso, R. Bacillus pumilus strain. USPTO 6,090,613 (US Patent and Trademark Office, 2000).
Jones, B. E. et al. Thermopallium bacteria and enzymes obtainable therefrom. USPTO 6,218,164 (US Patent and Trademark Office, 2001).
Jones, B. E. & Grant, W. D. (Genencor International, Inc.) Haloalkaliphilic microorganisms. USPTO 6,420,147 (US Patent and Trademark Office, 2002).
Bradfisch, G. A., Schenpf, H. E. & Kim, L. Bacillus thuringiensis isolates active against weevils. USPTO 6,605,462 (US Patent and Trademark Office, 2003).
Banfield, J. F. et al. Acidophile archaeal organism. USPTO 6,589,772 (US Patent and Trademark Office 2003).
Kelves, D. J. A History of Patenting Life in the United States with Comparative Attention to Europe and Canada (citation of Judge G.S. Rich's published legal opinion therein) 20 (Office for Official Publications of the European Communities, Luxembourg, 2002).
Eisenberg, R. S. Re-examining the role of patents in appropriating the value of DNA sequences. Emory Law J. 49, 783–800 (2000).
Maschio, T. & Kowalski, T. Bioinformatics — a patenting view. Trends Biotechnol. 19, 334–339 (2001).
Butler, D. Are you ready for the revolution? Nature 409, 758–760 (2001).
Bostyn, S. J. R. Living in an (imm)material world: bioinformatics and intellectual property protection. J. Int. Biotechnol. Law 1, 2–10 (2004).
Walsh, J. P., Arora, A. & Cohen, W. M. in Patents in the Knowledge-Based Economy (eds Cohen, W. M. & Merrill, S. A.) 285–340 (National Academies Press, Washington DC, 2003).
Resnik, D. B. DNA patents and scientific discovery and innovation: assessing benefits and risks. Sci. Eng. Ethics 7, 29–62 (2001).
Resnik, D. B. DNA patents and human dignity. J. Law Med. Ethics 29, 152–165 (2001).
Perry, M. Lifeform patents: the high and the low. J. Int. Biotechnol. Law 1, 20–27 (2004).
Lawrence, J. G., Hatfull, G. F. & Hendrix, R. W. Imbroglios of viral taxonomy: genetic exchange and failings of phenetic approaches. J. Bacteriol. 184, 4891–4905 (2002).
Gogarten, J. P., Doolittle, W. F. & Lawrence, J. G. Prokaryotic evolution in the light of gene transfer. Mol. Biol. Evol. 19, 2226–2238 (2002).
Seiki, M., Hattori, S., Hirayama, Y. & Yoshida M. Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proc. Natl Acad. Sci. USA 80, 3618–3622 (1983).
Kato, N. et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl Acad. Sci. USA 87, 9524–9528 (1990).
Pitcovski, J. et al. The complete DNA sequence and genome organization of the avian adenovirus, hemorrhagic enteris virus. Virology 249, 307–315 (1998).
Shigenobu, S., Watanabe, H., Hattori, M., Sakaki, Y. & Ishikawa, H. Genome sequence of the endocellular bacterial symbiont of aphids Buchnera sp APS. Nature 407, 81–86 (2000).
Reddick, B. B., Habera, L. F. & Law, M. D. Nucleotide sequence and taxonomy of maize chlorotic dwarf virus within the Sequiviridae. J. Gen. Virol. 78, 1165–1174 (1997).
de Haan, P., Wagemakers, L., Peters, D. & Goldbach, R. The S RNA segment of tomato spotted wilt virus has an ambisense character. J. Gen. Virol. 71, 1001–1007 (1990).
de Haan, P. et al. Tomato spotted wilt virus encodes a putative RNA polymerase. J. Gen. Virol. 72, 2207–2216 (1991).
Kormelink, R., de Haan, P., Meurs, C., Peters, D. & Goldbach, R. The nucleotide sequence of the M RNA segment of tomato spotted wilt virus, a bunyavirus with two ambisense RNA segements. J. Gen. Virol. 73, 2795–2804 (1992).
Fraser, C. M. et al. The minimal gene complement of Mycoplasma genitalium. Science 270, 397–403 (1995).
Fleischmann, R. D. et al. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269, 496–512 (1995).
Bult, C. J. et al. Complete genome sequence of the methanogenic archaeon, Methanococcus jannaschii. Science 273, 1058–1073 (1996).
Acknowledgements
We would like to thank W.F. Doolittle and two anonymous referees for several useful suggestions. The research for this paper was supported by the Economic and Social Research Council (ESRC), UK, as part of the programme of the ESRC's Centre for Genomics in Society (Egenis). A.B. also acknowledges a travel grant from the Chemical Heritage Foundation.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
Glossary
- BIOREMEDIATION
-
The use of microorganisms to degrade hazardous contaminants in soil and water to environmentally safe levels.
- CORONAVIRUS
-
A genus of virus named after the projections that create a crown-effect around the outside of each virus particle. They infect various mammals and birds, causing respiratory and enteric illness. The SARS-associated coronavirus is a previously unrecognized member of the genus with no close genetic relationship to known coronavirus sequences.
- ONCOMOUSE
-
(Also known as the Harvard mouse.) A type of laboratory mouse that is genetically modified to carry genes that increase susceptibility to cancer (oncogenes).
Rights and permissions
About this article
Cite this article
O'Malley, M., Bostanci, A. & Calvert, J. Whole-genome patenting. Nat Rev Genet 6, 502–506 (2005). https://doi.org/10.1038/nrg1613
Published:
Issue date:
DOI: https://doi.org/10.1038/nrg1613
This article is cited by
-
Defining the spectrum of genome policy
Nature Reviews Genetics (2006)
-
Ten years of bacterial genome sequencing: comparative-genomics-based discoveries
Functional & Integrative Genomics (2006)